Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Cancers
|
December 19, 2018
Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib
Lujun Shen, Mian Xi, Lei Zhao, et al.
Annals of Medicine
|
October 22, 2025
Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trials
Xingyuan Cheng, Kongjia Luo, Yilu Gao, et al.
Annals of Surgical Oncology
|
September 9, 2018
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies
Sha Zhou, Shiliang Liu, Li Zhang, et al.
Annals of Surgical Oncology
|
September 20, 2022
Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery
Zhaohui Liang, Kongjia Luo, Yuting Wang, et al.
Annals of Surgical Oncology
|
July 29, 2015
Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
Shi-Liang Liu, Mian Xi, Hong Yang, et al.
Eclinicalmedicine
|
September 16, 2024
Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial
Ruixi Wang, Yihong Ling, Baoqing Chen, et al.
Journal of Oncology
|
June 23, 2020
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study
Yizhen Fu, Mian Xi, Yangxun Pan, et al.
Plos One
|
June 6, 2013
Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis
Mian Xi, Li Zhang, Lei Zhao, et al.
International Journal of Surgery (London, England)
|
August 2, 2024
Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study
Yizhen Fu, Zhoutian Yang, Shiliang Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 6, 2012
The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin
Lei Zhao, Qiao-Qiao Li, Rui Zhang, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Cancers
|
December 19, 2018
Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib
Lujun Shen, Mian Xi, Lei Zhao, et al.
Annals of Medicine
|
October 22, 2025
Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trials
Xingyuan Cheng, Kongjia Luo, Yilu Gao, et al.
Annals of Surgical Oncology
|
September 9, 2018
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies
Sha Zhou, Shiliang Liu, Li Zhang, et al.
Annals of Surgical Oncology
|
September 20, 2022
Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery
Zhaohui Liang, Kongjia Luo, Yuting Wang, et al.
Annals of Surgical Oncology
|
July 29, 2015
Is There a Correlation Between Clinical Complete Response and Pathological Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Cancer?
Shi-Liang Liu, Mian Xi, Hong Yang, et al.
Eclinicalmedicine
|
September 16, 2024
Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial
Ruixi Wang, Yihong Ling, Baoqing Chen, et al.
Journal of Oncology
|
June 23, 2020
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study
Yizhen Fu, Mian Xi, Yangxun Pan, et al.
Plos One
|
June 6, 2013
Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis
Mian Xi, Li Zhang, Lei Zhao, et al.
International Journal of Surgery (London, England)
|
August 2, 2024
Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study
Yizhen Fu, Zhoutian Yang, Shiliang Liu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 6, 2012
The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin
Lei Zhao, Qiao-Qiao Li, Rui Zhang, et al.
Page
of 11